Propiedad y actividad de insiders de Castle Biosciences, Inc. (CSTL): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $35.48 |
| Capitalización | $1.1B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-11 | MAETZOLD DEREK J | M-Exempt | 8,584 | $21K |
| 2026-09-11 | MAETZOLD DEREK J | S-Sale | 8,361 | $268K |
| 2026-09-11 | MAETZOLD DEREK J | S-Sale | 223 | $7K |
| 2026-09-11 | MAETZOLD DEREK J | M-Exempt | 8,584 | $21K |
| 2026-09-11 | MAETZOLD DEREK J | S-Sale | 3,124 | $100K |
| 2026-09-11 | MAETZOLD DEREK J | S-Sale | 83 | $3K |
| 2026-09-11 | MAETZOLD DEREK J | S-Sale | 2,656 | $85K |
| 2026-09-11 | MAETZOLD DEREK J | S-Sale | 71 | $2K |
| 2026-09-01 | Oelschlager Kristen M | M-Exempt | 4,152 | $14K |
| 2026-09-01 | Oelschlager Kristen M | S-Sale | 3,952 | $132K |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $1.2M | $4.5M | $98.8M | $409.9M | $329.6M | $122.9M | $98.8M | $119.7M | $116.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $135.7M | $144.3M | $173.4M | $182.8M |
| Cuentas por Cobrar | $4.7M | $12.1M | $14.6M | $12.8M | $17.3M | $23.5M | $38.3M | $51.2M | $43.4M |
| Inventario | $304576 | $882233 | $1.2M | $2.2M | $2.0M | $4.0M | $7.9M | $8.1M | $10.3M |
| Activos Corrientes | $6.7M | $18.1M | $116.7M | $429.6M | $353.7M | $292.3M | $295.6M | $360.2M | $361.1M |
| Inmovilizado Material | $1.5M | $1.5M | $2.1M | $7.1M | $16.9M | $26.5M | $37.7M | $62.7M | $112.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | $10.7M | $10.7M | $10.7M | $10.7M |
| Activos Intangibles | $40119 | $4167 | 0 | 0 | $88.9M | $115.7M | $106.6M | $95.5M | $88.9M |
| Activos Totales | $9.8M | $22.4M | $119.7M | $439.3M | $462.6M | $447.3M | $453.3M | $531.2M | $578.6M |
| Cuentas por Pagar | $1.1M | $1.5M | $1.9M | $2.1M | $2.5M | $4.7M | $10.3M | $6.9M | $18.7M |
| Deuda a Corto | $1.0M | 0 | $5.8M | 0 | 0 | 0 | 0 | $278000 | $417000 |
| Pasivos Corrientes | $5.2M | $6.7M | $15.3M | $20.9M | $24.9M | $36.1M | $47.7M | $49.4M | $68.7M |
| Deuda a Largo | $17.6M | $24.5M | $19.3M | 0 | 0 | 0 | 0 | $9.7M | $9.6M |
| Pasivos Totales | $24.1M | $32.5M | $34.6M | $23.6M | $50.8M | $48.2M | $62.1M | $75.4M | $107.7M |
| Reservas | -$51.1M | -$57.5M | -$52.2M | -$62.5M | -$93.8M | -$160.9M | -$218.4M | -$200.1M | -$224.3M |
| Patrimonio Neto | -$14.3M | -$10.1M | $85.1M | $415.7M | $411.7M | $399.1M | $391.3M | $455.8M | $470.9M |
| Deuda Total | $18.6M | $24.5M | $25.1M | 0 | $8.2M | $13.4M | $15.3M | $26.3M | $36.9M |
| Deuda Neta | $17.4M | $20.0M | -$73.7M | -$409.9M | -$321.4M | -$245.2M | -$227.8M | -$266.8M | -$262.6M |
| Capital Circulante | $1.5M | $11.4M | $101.4M | $408.7M | $328.9M | $256.2M | $248.0M | $310.8M | $292.4M |
Salud financiera
| Deuda / Patrimonio | 0.08 |
| Ratio corriente | 6.04 |
Rentabilidad
| Rentabilidad sobre capital | -4.15% |
| Rentabilidad sobre capital invertido | -6.31% |
| Rentabilidad sobre activos | -3.46% |
| Margen bruto | 77.26% |
| Margen operativo | -8.99% |
| Margen neto | -5.43% |
Empresas relacionadas: AMN · CDNA · DRIO · EMBC · EVH · FLGT · GERN
Explorar sector: Healthcare · Medical - Diagnostics & Research
Más secciones de CSTL: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones